Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2016 1
2018 1
2019 1
2020 1
2021 5
2022 4
2023 2
2024 2

Text availability

Article attribute

Article type

Publication date

Search Results

15 results

Results by year

Filters applied: . Clear all
Page 1
Effects of clozapine treatment on the improvement of substance use disorders other than nicotine in individuals with schizophrenia spectrum disorders: A systematic review and meta-analysis.
Rafizadeh R, Danilewitz M, Bousman CA, Mathew N, White RF, Bahji A, Honer WG, Schütz CG. Rafizadeh R, et al. J Psychopharmacol. 2023 Feb;37(2):135-143. doi: 10.1177/02698811221142575. Epub 2022 Dec 12. J Psychopharmacol. 2023. PMID: 36507548 Free PMC article. Review.
Virtual twins for model-informed precision dosing of clozapine in patients with treatment-resistant schizophrenia.
Mostafa S, Rafizadeh R, Polasek TM, Bousman CA, Rostami-Hodjegan A, Stowe R, Carrion P, Sheffield LJ, Kirkpatrick CMJ. Mostafa S, et al. Among authors: rafizadeh r. CPT Pharmacometrics Syst Pharmacol. 2024 Mar;13(3):424-436. doi: 10.1002/psp4.13093. Epub 2024 Jan 19. CPT Pharmacometrics Syst Pharmacol. 2024. PMID: 38243630 Free PMC article.
Association of clozapine treatment and rate of methamphetamine or amphetamine relapses and abstinence among individuals with concurrent schizophrenia spectrum and amphetamine use disorder: A retrospective cohort study.
Rafizadeh R, Frankow L, Mahmood H, Poonia S, Mathew N, Danilewitz M, Bousman CA, Honer WG, Schütz CG. Rafizadeh R, et al. J Psychopharmacol. 2023 Oct;37(10):1040-1048. doi: 10.1177/02698811231191781. Epub 2023 Aug 4. J Psychopharmacol. 2023. PMID: 37539972 Free PMC article.
15 results